Viral Vector Contract Development and Manufacturing Organization (CDMO) Market Size & Share Analysis - Growth, Trends & Forecasts (2024-2029)

The Viral Vector Contract Development and Manufacturing Organization (CDMO) Market Report is Segmented by Vector Type (Adenovirus, Retrovirus, Adeno-Associated Virus, Lentivirus, and Others), Workflow (Upstream Manufacturing and Downstream Manufacturing), Application (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, and Other Applications), End User (Pharmaceutical & Biopharmaceutical Companies, and Research Institutes), and Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Report Offers the Value (USD) for all the Above Segments.

Viral Vector Contract Development and Manufacturing Organization (CDMO) Market Size & Share Analysis - Growth, Trends & Forecasts (2024-2029)

Viral Vector Contract Development and Manufacturing Organization (CDMO) Industry Overview

The viral vector CDMO market is moderately competitive and consists of several players globally. Companies are focusing more on receiving funding for manufacturing needs. Some of the key players operating in the market include ThermoFisher Scientific, Charles River Laboratories International, Inc., Catalent Inc., Creative Biogene, and Lonza.

Viral Vector Contract Development and Manufacturing Organization (CDMO) Market Leaders

  1. ThermoFisher Scientific

  2. Lonza

  3. Catalent Inc.

  4. Creative Biogene

  5. Charles River Laboratories International, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Concentration

Viral Vector Contract Development and Manufacturing Organization (CDMO) Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?